Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
Hidde C G OvertoomBen M EyckBerend J van der WilkBo Jan NoordmanPieter C van der SluisBas P L WijnhovenJ Jan B van LanschotSjoerd M Lagardenull nullPublished in: Annals of surgery (2024)
Prolonged TTS in patients with histologically proven residual disease after completion of nCRT for esophageal cancer did not have a negative effect on overall and disease-free survival, but patients did have a higher risk for postoperative respiratory complications.
Keyphrases
- free survival
- rectal cancer
- end stage renal disease
- locally advanced
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- patients undergoing
- risk factors
- peritoneal dialysis
- squamous cell carcinoma
- prognostic factors
- coronary artery bypass
- radiation therapy
- acute coronary syndrome
- respiratory tract